Author(s): Gabrielli E, Ferraioli G, Ferraris L, Riva A, Galli M, , Gabrielli E, Ferraioli G, Ferraris L, Riva A, Galli M,
Abstract Share this page
Abstract Enfuvirtide is a large protein that should be injected subcutaneously to ensure an appropriate absorption. Here we report the case of a transgender HIV-positive patient receiving enfuvirtide with an individualized background regimen of antiretroviral drugs, who had previously undergone liquid silicone oil injections. We performed US scan to detect silicone-free areas for following enfuvirtide injections. US can be useful in the correct management of those patients with liquid silicone oil soft tissue augmentation who require subcutaneously injected drugs.
This article was published in New Microbiol
and referenced in Journal of AIDS & Clinical Research